Florida report criticizes returns on biotech research subsidies; Forma partners with TGen;

@FierceBiotech: The Fierce team has landed in Boston. Check out our dedicated BIO2012 page. Special Coverage | Follow @FierceBiotech

@JohnCFierce: Quintiles (CRO) is expanding in China, building a regional HQ in Shanghai. Release | Follow @JohnCFierce

@RyanMFierce: Roche does an encore Alzheimer's deal with AC Immune worth up to $420M, focused on anti-Tau antibodies. More | Follow @RyanMFierce

> The Orlando Sentinel raises questions about the payback Florida received from the state's ambitious effort to subsidize the launch of new institutes for drug discovery as some of the new ventures fail to deliver on all the jobs which were promised. Story

> Forma Therapeutics and TGen Drug Development--TD2--today announced an agreement to jointly develop new cancer therapies. Release

> Chemical & Engineering News has an in-depth portrait on Immunogen and the long road traveled by antibody-drug conjugates. Story

> Birmingham, AL-based Soluble Therapeutics has won a $1 million NIH grant to develop new protein formulation technology for drug developers. Story

Pharma News

@FiercePharma: China's pharma industry blames toxic capsules on super-aggressive tendering, says corner-cutting won't stop. Report | Follow @FiercePharma

> FDA keeps door open to pharmacy versions of KV's Makena. More

> Biotest prepared to exit Greece for non-payment. Story

> Cipla chief aims for more cut-rate cancer drugs. Article

Medical Devices News

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> Oxford Immunotec pulls in $28M to boost TB Dx test. Story

> How can the FDA fix its device-approval process? Article

> Industry may be overstating effect of device tax. More

Biotech IT News

> Harvard IDs key human-hosted bugs with computer systems. More

> Third Rock fuels $41M launch of Bay Area biotech. Item

> Africa goes mobile to tackle drug safety woes. Story

And Finally... Researchers from the University of Houston have concluded that the most contaminated item you'll find in a hotel room is the TV remote. Release

 

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.